High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

Current Biology

Volumn 8, Issue 21, 1998, Pages 1169-1178

  Suzuki, Akira ^a   De La Pompa, José Luis ^a   Stambolic, Vuk ^a   Elia, Andrew J ^a   Sasaki, Takehiko ^a   Del Barco Barrantes, Ivan ^a   Ho, Alexandra ^a   Wakeham, Andrew ^a   Itie, Annick ^a   Khoo, Wilson ^a   Fukumoto, Manabu ^b   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE;

EID: 13144249184     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(07)00488-5     Document Type: Article

References (45)

1. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al.: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
2. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al.: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23 3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
3. Li DM, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997, 57:2124-2129.
4. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, et al.: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 1997, 57:5221-5225.
5. Bostrom J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, et al.: Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 1998, 58:29-33.
6. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, et al.: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997,57:4187-4190.
7. Feilotter HE, Nagai MA, Boag AH, Eng C, Mulligan LM: Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 1998, 16:1743-1748.
8. Wang SI, Parsons R, Ittmann M: Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res 1998, 4:811-815.
9. Kohno T, Takahashi M, Manda R, Yokota J: Inactivation of the PTEN/ MMACI/ ITEPI gene in human lung cancers. Genes Chromosomes Cancer 1998, 22:152-156.
10. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, et al.: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997, 57:3935-3940.
11. Risinger JI, Hayes AK, Berchuck A, Barrett JC : PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997, 57:4736-4738.
12. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 1997, 57:3657-3659.
13. Singh B, Ittmann MM, Krolewski JJ: Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 1998, 21:166-171.
14. Peters N, Wellenreuther R, Rollbrocker B, Hayashi Y, Meyer-Puttlitz B, Duerr EM, et al.: Analysis of the PTEN gene in human meningiomas. Neuropathol Appl Neurobiol 1998, 24:3-8.
15. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, et al.: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998, 58:204-209.
16. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al.: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16:64-67.
17. Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, et al.: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997, 6:1383-1387.
18. Eng C: Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 1998, 12:701-710.
19. Myers MP, Tonks NK: PTEN: sometimes taking it off can be better than putting it on. Am J Hum Genet 1997, 61:1234-1238.
20. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378.
21. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al.: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275:661-5.
22. Staal SP, Hartley JW: Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med 1988 167:1259-64.
23. Furnari FB, Lin H, Huang HJS, Cavenee WK: Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997, 94:12479-12484.
24. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998, 280:1614-1617.
25. Marsh DJ, Coulon V, Lunette KL, Rocca-Serra P, Dahia PL, Zheng Z, et al.: Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998, 7:507-515.
26. Kispert A, Herrmann BG : The Brachyury gene encodes a novel DNA binding protein. EMBO J 1993, 12:3211-20.
27. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al.: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
28. Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL: Essential role of Mash-2 in extraembryonic development. Nature 1994, 371:333-6.
29. Rossant J: Development of the extraembryonic lineages. Semin Dev Biol 1995 6:237-247.
30. Wilkinson DG, Bhatt S, Chavrier P, Bravo R, Charnay P: Segment-specific expression of a zinc-finger gene in the developing nervous system of the mouse. Nature 1989, 337:461-464.
31. Candia AF, Hu J, Crosby J, Lalley PA, Noden D, Nadeau JH, Wright CV: Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. Development 1992, 116:1123-36.
32. Wilkinson DG, Bailes JA, McMahon AP: Expression of the protooncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 1987, 50:79-88.
33. Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP: Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev 1994, 8:174-89.
34. Widmann C, Gibson S, Johnson GL: Caspase-dependent cleavage of signaling proteins during apoptosis A turn-off mechanism for anti-apoptotic signals. J Biol Chem 1998, 273:7141-7.
35. Cristofano AD, Pesce B, Cordon-Cardo C, Pandolfi PP: PTEN is essential for embryonic development and tumour suppression. Nat Genet 1998, 19348-355.
36. Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI: Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorio-allantoic fusion and placentation. Genes Dev 1995, 9:1-14.
37. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA: Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 1995, 121:489-503.
38. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et al.: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994, 8:1019-1029.
39. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994, 7:353-361.
40. Wang D, Enders GC: Expression of a specific mouse germ cell nuclear antigen (GCNA1) by early embryonic testicular teratoma cells in 129/Sv-SI/+ mice. Cancer Lett 1996, 100:31-36.
41. Harvey M, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A, Donehower LA: Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993, 5225-229.
42. Suzuki A, Andrew DP, Gonzalo JA, Fukumoto M, Spellberg J, Hashiyama M: CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood 1996, 87:3550-3562.
43. Suzuki A, de la Pompa JL, Hakem R, Elia A, Yoshida R, Mo R, et al.: Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev 1997, 11:1242-1252.
44. Koop KE, MacDonald LM, Lobe CG : Transcripts of Grg4, a murine groucho-related gene, are detected in adjacent tissues to other murine neurogenic gene homologues during embryonic development. Mech Dev 1996, 59:73-87.
45. Hui CC, Joyner AL: A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene. Nat Genet 1993, 3:241-246.